Village Farms International, Inc. today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada the seventh amendment to the cultivation license for its 1.1 million square foot greenhouse in Delta, BC (the "Delta 3 Facility"). This amendment permits Pure Sunfarms to expand its cannabis production area by approximately 206,000 square feet to a total of approximately 1.03 million square feet (16 grow rooms). With this amendment, the entire growing area at Pure Sunfarms' greenhouse is now licensed for cultivation. The newly licensed area is expected to be planted by the end of March 2019.

Village Farms also announced that Pure Sunfarms has, as planned, commenced re-planting of Quadrant 1 of its greenhouse following the planned suspension of production last autumn to install the infrastructure for supplemental lighting to maximize yields in the winter months. The Company expects Quadrant 1 to be fully planted by the end of April 2019, at which time Pure Sunfarms will be in production on the entire 1.03 million square feet of growing area at its facility, making it one of the largest fully operational cannabis production facilities in the world. Pure Sunfarms continues to expect to achieve full run rate annual production for its 1.1 million square foot greenhouse facility of 75,000 kilograms by mid-2019.

"It is a monumental achievement for Pure Sunfarms to complete its cultivation licensing of more than 1 million square feet and, very shortly, be in full commercial production - just over a year from receiving initial approval from Health Canada to begin growing," said Michael DeGiglio, Chief Executive Officer, Village Farms. "Pure Sunfarms has rapidly become one of the largest cannabis operations in Canada and is establishing itself as a reliable, large-scale supplier of quality, safe cannabis products to the Canadian market which continues to be challenged by a shortage of supply. With thousands of kilograms harvested, the Pure Sunfarms facility continues to perform well, with yield and quality of the product continuing to meet or exceed our expectations, and the team continues to execute on plan."

The Green Organic Dutchman Holdings Ltd. announced that it has entered into a multi-year extraction services contract with Valens GroWorks Corp.

Valens is a licenced provider of cannabis products and services specializing in various proprietary extraction, distillation, cannabinoid isolation and purification technologies. Partnering with Valens will accelerate TGOD's Canadian hemp strategy and allow for early market entry of TGOD's organic hemp-derived CBD product lines within the coming months.

Under the terms of the initial 2-year agreement, Valens will process, extract and purify TGOD's cannabis and hemp biomass under conditions specified by TGOD as demanded by final product manufacturing and formulation requirements. TGOD will supply Valens with significant quantities of cannabis and hemp and Valens will provide extraction purification services processing the cannabis and hemp into premium quality resins and distillates. TGOD intends to use the concentrated cannabinoid resins and distillates to produce oils, sprays and capsules as well as oils for vaporization and future edible, beverage and topical products.

TGOD has been working closely with Valens to help expedite the pathway to organic certification for Valens organic processing methodologies. Upon certification, TGOD will have exclusive access to services provided by Valens for certified organic extraction processing for a period of 1 year.

The demand for non-intoxicating hemp-derived CBD products has been strong and supported through significant patient and consumer research. Being first to market in Canada with organically certified hemp-derived CBD products allows TGOD to capture organic CBD market share securing future growth in this newly legalized cannabinoid vertical.

"The ability to partner with skilled and specialized extraction operators such as Valens will add significant bench strength to TGOD's already robust extraction capabilities in Canada, Poland and Jamaica. We believe the importance of high-quality cannabis oils will continue to greatly increase as patients and consumers look for safer and healthier delivery methods."

Aurora Cannabis Inc. today announced that it has commenced sales of cannabis oils to German pharmacies following receipt of all necessary approvals from the Canadian and German regulatory authorities. Pedanios 5/1 drops have become the first extract derived oil product compliant with the German monograph for in-pharmacy preparation.

Aurora is the medical cannabis market leader in Germany. The Company has supplied the German market with dried cannabis flower via Aurora Deutschland (formerly Pedanios) since December 2015, and with Canadian-grown Aurora products since September 2017. Aurora has established a strong brand as a trusted supplier among prescribing physicians, dispensing pharmacies, and German patients. As one of few companies able to sell oils in this rapidly growing market, Aurora is well positioned to establish brand leadership in the European derivatives market.

"Having established early mover advantage in selling cannabis oils in Germany, we are exceptionally positioned to extend our market leadership and accelerate growth of our European operations," said Neil Belot, Chief Global Business Development Officer. "As our global production capacity continues to ramp up, we are able to strategically allocate more product from our EU GMP certified cultivation facilities to this higher margin market that continues to be significantly undersupplied."

The LOI is the first step of Supreme Cannabis' application for a Cannabis Production License in Malta. Such License would allow the Company to produce and process cannabis for medical use within Malta, one of Europe's principal commercial entry points, and to export cannabis for medical use to certain international markets. If approved, Supreme Cannabis intends to produce products containing EU GMP quality cannabis oil and pursue regulated medical cannabis distribution opportunities in the European Union.

"We're pleased to announce that we have secured a letter of intent from Malta Enterprises, taking another step forward in our global growth strategy. Malta is not only a strategic hub for Europe, it is also home to robust existing pharmaceutical and nutraceutical manufacturing industries with a deep pool of expertise," said Navdeep Dhaliwal, CEO of The Supreme Cannabis Company. "Using the intellectual property and expertise we've gained in Canada, we intend to deliver high-quality cannabis products to medical patients in multiple international markets."

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/